MES-SA Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | MES-SA is a human uterine sarcoma cell line derived from the pleural effusion of an adult patient with high-grade uterine leiomyosarcoma. As a model of soft tissue sarcoma, MES-SA displays characteristics of mesenchymal origin, including spindle-shaped morphology and smooth muscle actin expression. Cytogenetic analysis of MES-SA reveals complex karyotypic abnormalities, including multiple numerical and structural chromosomal alterations. Importantly, this cell line is widely used in studies of multidrug resistance and chemotherapy response, due to its documented sensitivity to doxorubicin and the availability of its drug-resistant subline, MES-SA/Dx5. MES-SA exhibits wild-type p53 and retinoblastoma protein (Rb), making it a useful tool for studying drug responses in p53-competent backgrounds. In various functional genomics and proteomics screens, MES-SA has demonstrated consistent patterns of signal transduction pathway engagement, particularly those involving PI3K/Akt and MAPK pathways. Reverse-phase protein array profiling has confirmed the activity of these pathways and revealed protein expression signatures relevant to targeted therapy exploration. Moreover, the cell line is included in large-scale pharmacogenomic resources such as the Cancer Cell Line Encyclopedia, where it has been utilized for integrative analyses of drug sensitivity, genetic dependencies, and epigenetic modifications. Recent investigations into chromatin state and gene regulation in MES-SA have highlighted epigenetic vulnerabilities, particularly involving promoter methylation and histone modification patterns. MES-SA serves as a model system in studies of histone deacetylase inhibitors and agents targeting chromatin modifiers. Its inclusion in both reverse-phase protein array and DNA methylation databases further enhances its relevance in preclinical drug development, especially for sarcoma-focused therapeutics. Collectively, MES-SA provides a robust and well-characterized platform for investigating the molecular underpinnings of uterine sarcomas and for evaluating therapeutic strategies targeting mesenchymal tumors. |
|---|---|
| Organism | Human |
| Tissue | Uterus |
| Disease | Uterine corpus sarcoma |
| Synonyms | MESSA |
Characteristics
| Age | 56 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Fibroblast |
| Cell type | Epithelial like |
| Growth properties | Adherent |
Regulatory Data
| Citation | MES-SA (Cytion catalog number 305827) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1404 |
Biomolecular Data
| Tumorigenic | Yes; Yes, readily form colonies in soft agar. Yes, tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 10(7) cells. |
|---|---|
| Mutational profile | Mutation: Gene deletion, CDKN2A, Homozygous. Mutation, ARID1A, Simple, p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC), Heterozygous (Cosmic-CLP=908127), ARID1A, Simple, p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA), Heterozygous (Cosmic-CLP=908127), PTEN, Simple, p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT), Heterozygous (Cosmic-CLP=908127) |
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305827-111125 | Certificate of Analysis | 11. Dec. 2025 | 305827 |